Table 2.
Total | ||||
---|---|---|---|---|
Variable | No. | (%) | 5-Year CIR* | P |
Histologic type | 0.2 | |||
ADC | 116 | (77) | 17% | |
SCC | 35 | (23) | 34% | |
Gender | 0.38 | |||
Female | 91 | (60) | 17% | |
Male | 60 | (40) | 28% | |
Smoking history | 0.64 | |||
Never | 31 | (21) | 11% | |
Former | 109 | (72) | 24% | |
Current | 11 | (7) | 31% | |
Procedure§ | 0.032 | |||
≥Lobectomy | 105 | (70) | 16% | |
Limited | 46 | (30) | 35% | |
Visceral pleural invasion | 0.24 | |||
Absent | 121 | (80) | 20% | |
Present | 30 | (20) | 30% | |
Lymphatic invasion | 0.16 | |||
Absent | 99 | (66) | 20% | |
Present | 52 | (34) | 26% | |
Vascular invasion | 0.09 | |||
Absent | 101 | (67) | 18% | |
Present | 50 | (33) | 30% | |
Pathologic stage | 0.046 | |||
IA | 91 | (60) | 18% | |
IB | 60 | (40) | 29% |
*CIR: Cumulative Incidence of Recurrence
Significant P-values (<0.05) are shown in bold type
Histologic type: ADC, adenocarcinoma
SCC, squamous cell carcinoma
§ Procedure: ≥Lobectomy: Lobectomy, Bilobectomy, Pneumonectomy
Limited: Segmental resection, Wedge resection